Manipulating IL-10 signalling blockade for better immunotherapy

Cell Immunol. 2015 Feb;293(2):126-9. doi: 10.1016/j.cellimm.2014.12.012. Epub 2015 Jan 8.

Abstract

Interleukin 10 is a cytokine with the ability to reduce or terminate inflammation. Chronic viral infection, such as infection of chronic hepatitis B, hepatitis C and HIV, has increased levels of interleukin 10 in peripheral blood. Serum IL-10 levels are also high in certain cancers. Blocking IL-10 signalling at the time of immunisation clears chronic viral infection and prevents tumour growth in animal models. We review recent advances in this area, with the emphasis on potential use of this novel strategy to treat chronic viral infection and cancer in human.

Keywords: Immunotherapy; Interleukin 10; Vaccine.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • HIV Infections / immunology*
  • HIV Infections / therapy
  • Hepatitis B, Chronic / immunology*
  • Hepatitis B, Chronic / therapy
  • Hepatitis C, Chronic / immunology*
  • Hepatitis C, Chronic / therapy
  • Humans
  • Immunotherapy
  • Interleukin-10 / immunology*
  • Signal Transduction / immunology*
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / virology

Substances

  • Interleukin-10